September 2, 2011 -- SinoCubate announced its launch as an incubator/investor in privately held companies located in mainland China. To begin operations, SinoCubate has signed up Wei Wei Zhang, MD, PhD as a director and member of senior management. Dr. Zhang is a serial China-US entrepreneur who has been instrumental in eight biotech startups, a background that indicates SinoCubate will be interested in biopharmas. Previously a shell company, SinoCubate will now start operating with $5 million in share-based capital. More details....
Stock Symbol: (OTCBB: SBAT)
